MedDevices AI
By
Is Thermo Fisher’s $10B Q2 Surge the Inflection Point for AI-Powered Biopharma? How Will It Reshape the Life Sciences Landscape?
Key Highlights Financial Resilience and Strategic MarginsThermo Fisher Scientific’s Q2 2025 report showcases its fortress-like financial discipline. With…
Can hellocare.ai and Epic’s Native Integration Redefine AI-Driven Inpatient Care Across US Hospitals?
Key Takeaways Epic Integration Enhances Bedside Engagementhellocare.ai’s purpose-built virtual care device now supports Epic MyChart Bedside TV out…
Can Novo Nordisk and Fangzhou’s AI-Powered Partnership Reshape Chronic Disease Care in China’s Digital Health Boom?
Key Insights: Revolutionizing Chronic Disease ManagementChina faces one of the world’s highest burdens of chronic diseases, particularly diabetes…
Can Johnson & Johnson’s 6-Point AI Strategy Revolutionize Surgery, Drug Discovery, and Global Patient Care?
Key Highlights From Experimentation to Execution: Focused AI for Measurable OutcomesAfter piloting 900+ generative AI use cases, Johnson…
Could the Medtronic–Abbott Partnership Shift the Future of Diabetes Technology as FDA Clears MiniMed™ 780G for Broader Use?
Key Highlights Expanding Integration Through Abbott PartnershipThe U.S. FDA has cleared Medtronic’s SmartGuard™ algorithm as an interoperable automated…
Could Medtronic’s Hugo™ Robotic System Redefine Hernia Surgery for 1.5M Patients in the U.S.?
Key Highlights A Landmark Clinical Study for Robotic Hernia SurgeryMedtronic’s Enable Hernia Repair trial is the first Investigational…
